202 related articles for article (PubMed ID: 3032610)
1. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
von Graevenitz A; Zollinger-Iten J
Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.
Greenup P; Blazevic DJ
Appl Microbiol; 1971 Sep; 22(3):309-14. PubMed ID: 4330312
[TBL] [Abstract][Full Text] [Related]
3. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.
Traub WH
Chemotherapy; 1982; 28(5):363-8. PubMed ID: 6291867
[TBL] [Abstract][Full Text] [Related]
4. Localization of polysaccharide components in polymyxin B treated cells of Serratia marcescens.
Weber DA; Nadakavukaren MJ; Tsang JC
J Antibiot (Tokyo); 1978 Jul; 31(7):732-5. PubMed ID: 211111
[No Abstract] [Full Text] [Related]
5. Effect of polymyxin B on the synthesis of prodigiosin and its precursors in Serratia marcescens.
Tsang JC; Feng JS
J Antibiot (Tokyo); 1983 Nov; 36(11):1564-6. PubMed ID: 6317625
[No Abstract] [Full Text] [Related]
6. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
Traub WH; Kohl KH; Spohr M; Bauer D
Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
Traub WH
Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
[TBL] [Abstract][Full Text] [Related]
8. An unusual zone surrounding colistin discs in sensitivity tests of Serratia marcescens.
Annear DI; Hudson JA
Med J Aust; 1970 Apr; 1(17):840-1. PubMed ID: 4913361
[No Abstract] [Full Text] [Related]
9. Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii.
Stock I; Grueger T; Wiedemann B
Int J Antimicrob Agents; 2003 Jul; 22(1):35-47. PubMed ID: 12842326
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymyxin B on kappa phage adsorption on Serratia marcescens HY.
Patel KA; Patel IR; Mehta AM; Dave PJ
Indian J Exp Biol; 1980 Nov; 18(11):1353-4. PubMed ID: 6260637
[No Abstract] [Full Text] [Related]
11. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.
Traub WH; Kleber I
Chemotherapy; 1975; 21(3-4):189-204. PubMed ID: 169108
[TBL] [Abstract][Full Text] [Related]
12. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
Gales AC; Reis AO; Jones RN
J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
[TBL] [Abstract][Full Text] [Related]
13. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
Larsen JL; Søgaard H
Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
[No Abstract] [Full Text] [Related]
14. Enhancement by polymyxin B of proline-induced prodigiosin biosynthesis in non-proliferating cells of Serratia marcescens.
Lauferska U; Viñas M; Lorén JG; Guinea J
Microbiologica; 1983 Apr; 6(2):155-62. PubMed ID: 6306401
[No Abstract] [Full Text] [Related]
15. L-prolineaminopeptidase activity as a tool for identification and differentiation of Serratia marcescens, Serratia liquefaciens and Hafnia alvei strains.
Fanghänel S; Reissbrodt R; Giesecke H
Zentralbl Bakteriol; 1991 Apr; 275(1):11-5. PubMed ID: 1930558
[TBL] [Abstract][Full Text] [Related]
16. Chemical and electrophoretic changes induced by polymyxin B on outer membrane components from Serratia marcescens.
Brown DA; Tsang JC
J Antibiot (Tokyo); 1978 Jun; 31(6):603-9. PubMed ID: 210151
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopic observations of polysaccharide components in polymyxin B treated outer membranes from Serratia marcescens.
Weber DA; Nadakavukaren MJ; Tsang JC
J Antibiot (Tokyo); 1979 Jan; 32(1):66-72. PubMed ID: 83989
[TBL] [Abstract][Full Text] [Related]
18. [Enrichment of auxotrophic mutants of Serratia marcescens by means of antibiotics].
Stamminger G; Schwager M; Kaplan RW
Arch Mikrobiol; 1970; 73(3):231-7. PubMed ID: 4922627
[No Abstract] [Full Text] [Related]
19. Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.
Ostenson RC; Fields BT; Nolan CM
Antimicrob Agents Chemother; 1977 Dec; 12(6):655-9. PubMed ID: 201214
[TBL] [Abstract][Full Text] [Related]
20. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
